Dysregulation of metabolism and cancer-related pathways (metabolic pathways, pathways in cancer, calcium signaling, insulin signaling, cell adhesion, axon guidance, etc) could possibly function in promoting malignant transformation of HFHC-livers (Supplementary Fig. 2). The gene discussed is INS; the disease is cancer.